Trump's $5.3 Trillion "Manhattan Project"

Trump just launched a $5.3T AI-powered missile shield-America's modern "Manhattan Project." While defense giants scramble, one tiny firm is already 40x smaller than Lockheed... yet leads anti-drone tech in 300+ defense programs. With $1.3B in contracts, this stock could soar.

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Avi Kapoor
April 11, 2024

Shares of Fastenal Company (NASDAQ:FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Fastenal reported first-quarter FY24 sales growth of 1.9% Y/Y to $1.895 billion, missing the consensus of $1.914 billion. The company's first-quarter EPS was 52 cents, missing the consensus of 53 cents.

Fastenal shares dipped 6.7% to $69.73 on Thursday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Rallybio Corporation (NASDAQ:RLYB) shares climbed 89.6% to $3.09 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.
  • Rent the Runway, Inc. (NASDAQ:RENT) shares jumped 74.5% to $12.91 after the company reported mixed fourth-quarter financial results and issued guidance.
  • Eliem Therapeutics, Inc. (NASDAQ:ELYM) jumped 59.6% to $4.2650. The company announced that it entered into a definitive acquisition agreement to acquire Tenet and it also entered into a securities purchase agreement for a $120 million private placement.
  • Akanda Corp. (NASDAQ:AKAN) gained 36% to $0.1632. Akanda, last month, announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry.
  • Alpine Immune Sciences, Inc. (NASDAQ:ALPN) rose 36.6% to $64.25 after Vertex entered into an agreement to acquire the company.
  • Candel Therapeutics, Inc. (NASDAQ:CADL) surged 29.6% to $6.61 after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer.
  • Enliven Therapeutics, Inc. (NASDAQ:ELVN) gained 26% to $24.97. Enliven Therapeutics announced proof of concept data from Phase 1 clinical trial of ELVN-001 in chronic myeloid leukemia.
  • Selina Hospitality PLC (NASDAQ:SLNA) rose 21.1% to $0.0923.
  • Globavend Holdings Limited (NASDAQ:GVH) climbed 16.8% to $1.68.
  • Janux Therapeutics, Inc. (NASDAQ:JANX) gained 16.8% to $52.15 following Wednesday reports suggesting the company is said to weigh a possible sale.
  • SciSparc Ltd. (NASDAQ:SPRC) shares rose 15.3% to $1.9357.
  • Gyre Therapeutics, Inc. (NASDAQ:GYRE) gained 14.6% to $15.91.
  • AnaptysBio, Inc. (NASDAQ:ANAB) climbed 11.4% to $24.72. Wells Fargo analyst Derek Archila initiated coverage on AnaptysBio with an Overweight rating and announced a price target of $56.
  • Verb Technology Company, Inc. (NASDAQ:VERB) gained 10.4% to $0.2010 after gaining 4% on Wednesday.
  • GigaCloud Technology Inc. (NASDAQ:GCT) rose 10.2% to $34.18.
  • Nurix Therapeutics, Inc. (NASDAQ:NRIX) gained 9.6% to $17.21. Baird analyst Joel Beatty maintained Nurix Therapeutics with an Outperform and raised the price target from $24 to $25.
  • StepStone Group LP (NASDAQ:STEP) rose 7.1% to $37.46 after JP Morgan upgraded the stock from Neutral to Overweight.

Losers

  • Aptevo Therapeutics Inc. (NASDAQ:APVO) shares fell 58% to $1.01 after the company priced its $4.6 million public offering.
  • Enlivex Therapeutics Ltd. (NASDAQ:ENLV) fell 54.5% to $1.81. The company announced topline results of its Phase II trial evaluating Allocetra in sepsis.
  • AVITA Medical, Inc. (NASDAQ:RCEL) fell 28.6% to $10.31 after the company announced an update to its expected commercial revenue for the first quarter of 2024. BTIG downgraded the stock from Buy to Neutral.
  • Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) fell 19% to $0.3723.
  • Globe Life Inc. (NYSE:GL) fell 14.6% to $89.65.
  • The Lovesac Company (NASDAQ:LOVE) shares fell 14.3% to $20.00 after the company reported worse-than-expected fourth-quarter results and issued first-quarter guidance.
  • Globe Life Inc. (NYSE:GL) fell 13.7% to $90.56.
  • Meiwu Technology Company Limited (NASDAQ:WNW) shares declined 12.4% to $1.1601 after jumping around 32% on Wednesday.
  • Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 12% to $0.7660 after declining 14% on Wednesday. Acorda Therapeutics recently commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.
  • CarMax, Inc. (NYSE:KMX) fell 11.7% to $70.02 after the company reported lower-than-expected fourth-quarter earnings.
  • VBI Vaccines Inc. (NASDAQ:VBIV) dipped 11.3% to $0.5641.
  • Nikola Corporation (NASDAQ:NKLA) fell 11.3% to $0.8680. On April 9, Wolfe Research analyst Scott Group initiated coverage on Nikola with a Peer Perform rating.
  • Marin Software Incorporated (NASDAQ:MRIN) declined 10.8% to $0.5798.
  • SolarBank Corporation (NASDAQ:SUUN) fell 9.3% to $5.29. SolarBank closed purchase of 3.15 MW solar project in New York from Storke Renewable.
  • Esperion Therapeutics, Inc. (NASDAQ:ESPR) fell 9.1% to $2.29.
  • 9F Inc. (NASDAQ:JFU) fell 8.8% to $2.7046.
  • iCoreConnect Inc. (NASDAQ:ICCT) shares fell 8.5% to $1.55 after jumping over 50% on Wednesday.
  • ClearOne, Inc. (NASDAQ:CLRO) declined 8.3% to $1.00. The company recently reported fourth-quarter financial results.
  • Nyxoah S.A. (NASDAQ:NYXH) fell 7.3% to $9.83
  • Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 6.2% to $0.8164.
  • Walker & Dunlop, Inc. (NYSE:WD) fell 5.3% to $87.71 after Wedbush downgraded the stock from Outperform to Neutral and lowered its price target from $130 to $95.

 

Now Read This: Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Quarter

Continue Reading...

Popular

What's in the latest version of Trump's big bill moving through the Senate

WASHINGTON (AP) — Republicans are inching closer to getting their tax and spending cut bill through Congress with a final Senate vote likely late Monday or early Tuesday.

The Next Palantir? Does This Under $5 AI Stock Have The Potential To Rise And Shine

This micro-cap AI stock is being increasingly touted as the next Palantir Technologies Inc. (NASDAQ: PLTR), but some analysts disagree with this framing.

A 64% Dividend From Gold? - Ad

Gold is soaring. But here's what no one's talking about: a way to earn a 64% dividend-paid in real cash every 30 days. No trading. No risky mining stocks. Just one simple move in your brokerage account... and you could start collecting monthly income almost instantly.

This Stock Just Popped 30% In 5 Days — Now Expert Says It 'Looks Potentially Explosive'

Experts have been betting on the growth prospects of Oscar Health, as it surged by 16.51% on Wednesday and 32.56% in the last five days.

Mystery Seller Behind $105 Million Plot Next to Jeff Bezos Estate Finally Revealed

A plot of land neighboring Jeff Bezos' property in Miami was sold for a staggering $105 million. The undeveloped lot was sold by German investor Mikhail Peleg.

Maverick Trader Reveals 97% Accurate System - Ad

This man's simple strategy makes money in any market...With a 97% accuracy at hitting winners over the past 8 years!

Elon Musk Recently Said 'Yes' To Impeaching Trump And The Odds Of That Happening In 2025 Rose On This Crypto Betting Market

The odds that President Donald Trump would be impeached this year saw a spike on Polymarket after tech mogul Elon Musk backed a call to remove him from office. 

How High Will Gold Surge? - Ad

Gold is on fire - hitting $3,500 and outpacing stocks, tech, even Bitcoin. Analyst Sean Brodrick called it, and now he's forecasting a surge to $6,900. But the biggest opportunity isn't bullion. It's a little-known investment that's returned up to 1,000x more than physical gold.

Sig Sauer, faced with lawsuits over a popular pistol, gets protection in New Hampshire

CONCORD, N.H. (AP) — Faced with mounting lawsuits over a popular pistol, New Hampshire-based Sig Sauer asked for — and got — protection in the form of a new state law that makes it harder to .

ICE arrests 84 people at Louisiana racetrack

NEW ORLEANS (AP) — The U.S. Immigration and Customs Enforcement arrested 84 people unlawfully in the country during a raid at a southwest Louisiana racetrack, the agency announced Tuesday.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.

Oracle Launches New Defense Program To Help US Military Tap Into AI And Cloud Tech

Oracle Corp announced the Oracle Defense Ecosystem, a global initiative to enhance technology innovation for defense & government sectors.

The Stock Ticker Notable Investors Are Holding - Ad

They may not be trading on public markets, but Pacaso just reserved the ticker PCSO. Co-founded by the man who took Zillow from seed to IPO, Pacaso brings co-ownership to a $1.3T market. They've earned $110M+ in gross profits already. Well-known firms like Maveron even invested.

Wall Street Legend: Trump Tariffs Will Accelerate the Greatest Wealth Transfer in History - Ad

A financial insider with decades on Wall Street has released a controversial video. He reveals the unseen connection between Trump's economic vision and a technological revolution. This hidden synergy is creating both unprecedented wealth and poverty. What can you do about it?

These are the celebs who are attending Jeff Bezos’ Venice wedding

VENICE, Italy (AP) — arrived in Venice on Thursday, leading a star-studded guest list of celebrities descending on the lagoon city for the weekend wedding of Amazon founder Jeff Bezos and Lauren Sánchez.

Elon's New Tech Bigger Than "DOGE Dividends"? - Ad

Musk's new tech-unrelated to DOGE-could hand Americans an extra $30,000 this year and beyond. While rumors swirl about a $5,000 "DOGE dividend," this breakthrough could be far more profitable. Discover the tiny tech driving the next big market move.

Bernie Sanders Shares First Thing He Would Do As President — And It Could Be A Jab At Elon Musk

Bernie Sanders lost the 2016 and 2020 presidential races. In a recent interview, Sanders shared what he would do first if he were president.

Home to North Carolina iconic attraction reopens after Hurricane Helene's devastation

CHIMNEY ROCK, N.C. (AP) — An iconic tourist attraction in an area of western North Carolina among the hardest hit by reopened to the public on Friday, nine months after the storm brought historic flooding, destruction and loss of life.

This Is the NEXT Palantir - Ad

Forget ChatGPT. Forget Google. The biggest AI winner? Palantir-arming the Pentagon while others chased chatbots. Its stock surged 1,759%. Now Trump's $5.3T "Golden Dome" missile shield is here-and one tiny AI firm is at the center, embedded in 300+ defense programs. Missed Palantir? This is your shot.

Bitcoin's Current Cycle Sees A 656% Surge, Matching Market Maturation Pace

Bitcoin (CRYPTO: BTC), the leading cryptocurrency globally, has recorded a 656% surge in its ongoing cycle.

How to Hack a $1.3T Market - Ad

Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.

International Space Station welcomes its first astronauts from India, Poland and Hungary

CAPE CANAVERAL, Fla. (AP) — The first astronauts in more than 40 years from India, Poland and Hungary arrived at the International Space Station on Thursday, ferried there by SpaceX on a private flight.

Limited Impact On Intuitive Surgical From Reprocessed Robotic Instruments: Analyst

Intuitive Surgical remains in focus as analysts weigh reprocessing risks after Restore Robotics secures FDA clearance for remanufactured tools.

Trump's $5.3 Trillion "Manhattan Project" - Ad

Trump just launched a $5.3T AI-powered missile shield-America's modern "Manhattan Project." While defense giants scramble, one tiny firm is already 40x smaller than Lockheed... yet leads anti-drone tech in 300+ defense programs. With $1.3B in contracts, this stock could soar.

FDA requires updated warning about rare heart risk with COVID shots

WASHINGTON (AP) — said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men.

Cathie Wood's Thursday Crypto Moves: Ark Unloads Nearly $25 Million In Coinbase, Block Stocks

On Thursday, Cathie Wood-led Ark Invest made notable trades, including the sale of shares in Coinbase Global Inc. (NASDAQ:COIN) and Block Inc. (NYSE:XYZ).

A 64% Dividend From Gold? - Ad

Gold is soaring. But here's what no one's talking about: a way to earn a 64% dividend-paid in real cash every 30 days. No trading. No risky mining stocks. Just one simple move in your brokerage account... and you could start collecting monthly income almost instantly.

Steve Jobs Took Secrecy To Fight Club Levels For This Critical Mission At Apple — 'People Thought They Knew…But Nobody Knew'

Apple's original iPhone team, under Steve Jobs, operated with intense secrecy, likening their work to "Fight Club," with no one outside the core group knowing the device's design until its 2007 debut.

Maverick Trader Reveals 97% Accurate System - Ad

This man's simple strategy makes money in any market...With a 97% accuracy at hitting winners over the past 8 years!

The Latest: NATO leaders gathering for key summit

NATO member leaders, including U.S. President Donald Trump, were gathering for in the Netherlands on Wednesday.

How High Will Gold Surge? - Ad

Gold is on fire - hitting $3,500 and outpacing stocks, tech, even Bitcoin. Analyst Sean Brodrick called it, and now he's forecasting a surge to $6,900. But the biggest opportunity isn't bullion. It's a little-known investment that's returned up to 1,000x more than physical gold.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright markethundred.com
Privacy Policy | Terms of Service